Global /China /Healthcare /Drug Manufacturers - General /300204

Staidson (Beijing) BioPharmaceuticals Co., Ltd.

300204

• SHE: 300204 • Delayed

27.63CNY -0.8%

4.08 USD

As of 16 June 2026, Staidson (Beijing) BioPharmaceuticals Co., Ltd. has a market cap of $1.97B USD, ranking #7138 globally and #1753 in China. It ranks #574 in the Healthcare sector, and #225 in the Drug Manufacturers - General industry.

Global Rank

7138

Country Rank

1753

Sector Rank

574

Industry Rank

225

Key Stats

Market Cap

$1.97BUSD

13.31B CNY

Enterprise Value

$1.96BUSD

13.28B CNY

Revenue (TTM)

$30.11MUSD

203.92M CNY

EBITDA (TTM)

-$8.22MUSD

-55.6M CNY

Net Income (TTM)

-$12.38MUSD

-83.86M CNY

EBITDA Margin

-27%

Profit Margin

-41%

PS Ratio

65.3

PB Ratio

16.7

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Wang Chao open_in_new

Employees

484

Founded

2002

Website

staidson.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.8%	-4.3%	-0.5%	8.4%	-18%	1.1%	154%	142%	227%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	300204 舒泰神(北京)生物制药股份有限公司 Class A ISIN: CNE100001237 Shares Out.: Shares Outstanding: 477.773M¹ Shares Float: 435.513M² TV: TradingView: SZSE: 300204 SA: Stock Analysis: SHE: 300204 YF: Yahoo Finance: 300204.SZ GF: Google Finance: SHE: 300204 BA: Barron's: 300204 MS: Morningstar: XSHE: 300204	27.63 CNY	TV: TradingView: SZSE: 300204 SA: Stock Analysis: SHE: 300204 YF: Yahoo Finance: 300204.SZ GF: Google Finance: SHE: 300204 BA: Barron's: 300204 MS: Morningstar: XSHE: 300204

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Staidson (Beijing) BioPharmaceuticals Co., Ltd.

Staidson (Beijing) BioPharmaceuticals Co., Ltd. primarily engages in the research and development, production, and marketing of therapeutic and biological drugs in China. The company offers protein drugs, including therapeutic monoclonal antibody drugs; chemical drugs; and drugs for urinary, intestinal, infectious, autoimmune, nervous system, and other diseases. Its product portfolio includes Mouse Nerve Growth factor for injection, Compound Polyethylene Glycol Electrolyte Powder (IV), Troponium Chloride Capsules, Gliclazide extended-release tablets, Aspirin enteric-coated tablets, Compound polyethylene glycol (3350) electrolyte oral solution, Compound polyethylene glycol (3350) electrolyte vitamin C. Staidson (Beijing) BioPharmaceuticals Co., Ltd. was founded in 2002 and is based in Beijing, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.89B 364.89B CNY 3K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.67B 336.36B CNY 2K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 1K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 857%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.52B 111.89B CNY 741%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 715%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 39K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 28K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 18K%	97.4	United States
Roche Holding AG SIX: RO	$320.51B 256.25B CHF 16K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.14B 215.59B GBP 15K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 14K%	15.1	United States

chevron_leftBack